Vanderbilt University Medical Center, 1161 21(st) Avenue South, Room D5203 MCN, Nashville, TN 37232-2577, United States of America.
Prog Cardiovasc Dis. 2018 Jul-Aug;61(2):253-269. doi: 10.1016/j.pcad.2018.06.003. Epub 2018 Jun 25.
Obesity is a chronic and debilitating disease that has become a global epidemic. Especially severe in the Unites States, obesity currently affects almost 40% of the population. Obesity has a strong causal relationship with numerous serious comorbidities that impair quality of life, shorten life expectancy, and carry a major economic burden. Obesity has particular relevance to cardiologists because it contributes directly to several major cardiovascular diseases and, consequently, increases overall cardiovascular mortality. Multiple treatment options are available, but metabolic and bariatric surgery offers the most effective and durable treatment for obesity. Moreover, metabolic and bariatric operations alleviate and often completely eliminate numerous comorbidities, particularly type 2 diabetes and other cardiovascular risk factors, such as hypertension and dyslipidemia. With their low risk of complications and morbidity, metabolic and bariatric operations significantly improve quality of life and overall survival, particularly reducing death due to cardiovascular disease.
肥胖是一种慢性且使人虚弱的疾病,已成为全球性的流行疾病。在美国尤为严重,肥胖目前影响近 40%的人口。肥胖与许多严重的合并症有着很强的因果关系,这些合并症会降低生活质量、缩短预期寿命,并带来巨大的经济负担。肥胖与心脏病专家特别相关,因为它直接导致了几种主要的心血管疾病,从而增加了整体心血管死亡率。有多种治疗选择,但代谢和减重手术是肥胖症最有效和持久的治疗方法。此外,代谢和减重手术缓解并常常完全消除许多合并症,特别是 2 型糖尿病和其他心血管危险因素,如高血压和血脂异常。由于并发症和发病率低,代谢和减重手术显著改善了生活质量和整体生存率,特别是降低了心血管疾病导致的死亡。